Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
about
Interaction between Tat and Drugs of Abuse during HIV-1 Infection and Central Nervous System DiseaseHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsHIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Effects of HIV-1 Tat on enteric neuropathogenesis.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.Morphine exposure during HIV encephalitis in SCID mice.Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors.Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and β-arrestin 2 activity in the forebrain.CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.Doxycycline-inducible and astrocyte-specific HIV-1 Tat transgenic mice (iTat) as an HIV/neuroAIDS model.Reduced intraepidermal nerve fibre density, glial activation, and sensory changes in HIV type-1 Tat-expressing female mice: involvement of Tat during early stages of HIV-associated painful sensory neuropathy.
P2860
Q26770397-6B9D0EE0-C241-429C-9A03-CBCF35BFDA0BQ28392199-99FFE23F-0F55-40B7-86EE-10E42AC79D75Q33647438-59DEF71B-DBDC-465A-95E2-00957C8F9B08Q34383417-4437A5AC-FEDE-4FC7-A2EA-CBD8FE005149Q35007339-9EC647E8-8519-4B84-AB08-EBBB9C974DA4Q36407266-82508F92-DDF9-4161-BE6E-9E75614926B1Q36432328-24DBA1F3-E9FE-4FAB-BBC1-B1DFE4AE2078Q36687603-45430788-6309-4767-8045-DE629962C148Q37399037-230BECFF-8AA0-4221-A7D4-8C6C4D72F98FQ38803243-90C11824-4FC3-479B-B083-F481E6057EC8Q42715611-7B6DD9C8-2BD5-48D6-93D7-0503302BA3D2Q45073147-D94F7AB4-C1FC-4FED-AC78-4E8AEF016105Q47397529-7DDCFEDE-9F6F-427F-B484-1CC95D62A0BEQ55315288-21E0EC1D-711E-4094-94B1-E2A639278392
P2860
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
@ast
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
@en
type
label
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
@ast
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
@en
prefLabel
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
@ast
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.
@en
P2093
P2860
P1476
Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice
@en
P2093
Krista L Scoggins
Kurt F Hauser
Pamela E Knapp
Ruqiang Xu
Seth M Dever
William L Dewey
P2860
P304
P356
10.1016/J.EJPHAR.2012.05.029
P407
P577
2012-05-30T00:00:00Z